109 related articles for article (PubMed ID: 36257192)
1. Hyperacetylation of the C-terminal domain of p53 inhibits the formation of the p53/p21 complex.
Kim U; Kim KS; Park JK; Um HD
Biochem Biophys Res Commun; 2022 Dec; 635():52-56. PubMed ID: 36257192
[TBL] [Abstract][Full Text] [Related]
2. Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1).
Zhao Y; Lu S; Wu L; Chai G; Wang H; Chen Y; Sun J; Yu Y; Zhou W; Zheng Q; Wu M; Otterson GA; Zhu WG
Mol Cell Biol; 2006 Apr; 26(7):2782-90. PubMed ID: 16537920
[TBL] [Abstract][Full Text] [Related]
3. Trichostatin A causes p53 to switch oxidative-damaged colorectal cancer cells from cell cycle arrest into apoptosis.
Habold C; Poehlmann A; Bajbouj K; Hartig R; Korkmaz KS; Roessner A; Schneider-Stock R
J Cell Mol Med; 2008 Apr; 12(2):607-21. PubMed ID: 18419600
[TBL] [Abstract][Full Text] [Related]
4. The multifunctional sorting protein PACS-2 regulates SIRT1-mediated deacetylation of p53 to modulate p21-dependent cell-cycle arrest.
Atkins KM; Thomas LL; Barroso-González J; Thomas L; Auclair S; Yin J; Kang H; Chung JH; Dikeakos JD; Thomas G
Cell Rep; 2014 Sep; 8(5):1545-57. PubMed ID: 25159152
[TBL] [Abstract][Full Text] [Related]
5. HIPK2 modulates p53 activity towards pro-apoptotic transcription.
Puca R; Nardinocchi L; Sacchi A; Rechavi G; Givol D; D'Orazi G
Mol Cancer; 2009 Oct; 8():85. PubMed ID: 19828042
[TBL] [Abstract][Full Text] [Related]
6. Novel histone deacetylase inhibitor CG200745 induces clonogenic cell death by modulating acetylation of p53 in cancer cells.
Oh ET; Park MT; Choi BH; Ro S; Choi EK; Jeong SY; Park HJ
Invest New Drugs; 2012 Apr; 30(2):435-42. PubMed ID: 20978925
[TBL] [Abstract][Full Text] [Related]
7. SPRR2A enhances p53 deacetylation through HDAC1 and down regulates p21 promoter activity.
Mizuguchi Y; Specht S; Lunz JG; Isse K; Corbitt N; Takizawa T; Demetris AJ
BMC Mol Biol; 2012 Jun; 13():20. PubMed ID: 22731250
[TBL] [Abstract][Full Text] [Related]
8. ING1 represses transcription by direct DNA binding and through effects on p53.
Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
[TBL] [Abstract][Full Text] [Related]
9. The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene.
Lagger G; Doetzlhofer A; Schuettengruber B; Haidweger E; Simboeck E; Tischler J; Chiocca S; Suske G; Rotheneder H; Wintersberger E; Seiser C
Mol Cell Biol; 2003 Apr; 23(8):2669-79. PubMed ID: 12665570
[TBL] [Abstract][Full Text] [Related]
10. SIRT1 knockdown up-regulates p53 and p21/Cip1 expression in renal adenocarcinoma cells but not in normal renal-derived cells in a deacetylase-independent manner.
Fujino T; Yokokawa R; Oshima T; Hayakawa M
J Toxicol Sci; 2018; 43(12):711-715. PubMed ID: 30518708
[TBL] [Abstract][Full Text] [Related]
11. Sirt-1 Regulates Physiological Process and Exerts Protective Effects against Oxidative Stress.
Liu L; Xia G; Li P; Wang Y; Zhao Q
Biomed Res Int; 2021; 2021():5542545. PubMed ID: 33834065
[TBL] [Abstract][Full Text] [Related]
12. Green tea polyphenols increase p53 transcriptional activity and acetylation by suppressing class I histone deacetylases.
Thakur VS; Gupta K; Gupta S
Int J Oncol; 2012 Jul; 41(1):353-61. PubMed ID: 22552582
[TBL] [Abstract][Full Text] [Related]
13. Sirt1 overexpression suppresses fluoride-induced p53 acetylation to alleviate fluoride toxicity in ameloblasts responsible for enamel formation.
Suzuki M; Ikeda A; Bartlett JD
Arch Toxicol; 2018 Mar; 92(3):1283-1293. PubMed ID: 29185024
[TBL] [Abstract][Full Text] [Related]
14. Methylation-acetylation interplay activates p53 in response to DNA damage.
Ivanov GS; Ivanova T; Kurash J; Ivanov A; Chuikov S; Gizatullin F; Herrera-Medina EM; Rauscher F; Reinberg D; Barlev NA
Mol Cell Biol; 2007 Oct; 27(19):6756-69. PubMed ID: 17646389
[TBL] [Abstract][Full Text] [Related]
15. The histone acetyltransferase PCAF regulates p21 transcription through stress-induced acetylation of histone H3.
Love IM; Sekaric P; Shi D; Grossman SR; Androphy EJ
Cell Cycle; 2012 Jul; 11(13):2458-66. PubMed ID: 22713239
[TBL] [Abstract][Full Text] [Related]
16. Lysines in the tetramerization domain of p53 selectively modulate G1 arrest.
Beckerman R; Yoh K; Mattia-Sansobrino M; Zupnick A; Laptenko O; Karni-Schmidt O; Ahn J; Byeon IJ; Keezer S; Prives C
Cell Cycle; 2016 Jun; 15(11):1425-38. PubMed ID: 27210019
[TBL] [Abstract][Full Text] [Related]
17. Specific acetylation of p53 by HDAC inhibition prevents DNA damage-induced apoptosis in neurons.
Brochier C; Dennis G; Rivieccio MA; McLaughlin K; Coppola G; Ratan RR; Langley B
J Neurosci; 2013 May; 33(20):8621-32. PubMed ID: 23678107
[TBL] [Abstract][Full Text] [Related]
18. ZNF509S1 downregulates PUMA by inhibiting p53K382 acetylation and p53-DNA binding.
Jeon BN; Yoon JH; Han D; Kim MK; Kim Y; Choi SH; Song J; Kim KS; Kim K; Hur MW
Biochim Biophys Acta Gene Regul Mech; 2017 Sep; 1860(9):962-972. PubMed ID: 28757384
[TBL] [Abstract][Full Text] [Related]
19. Omentin-1, a new adipokine, promotes apoptosis through regulating Sirt1-dependent p53 deacetylation in hepatocellular carcinoma cells.
Zhang YY; Zhou LM
Eur J Pharmacol; 2013 Jan; 698(1-3):137-44. PubMed ID: 23178529
[TBL] [Abstract][Full Text] [Related]
20. Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function.
Nihira NT; Ogura K; Shimizu K; North BJ; Zhang J; Gao D; Inuzuka H; Wei W
Sci Signal; 2017 Feb; 10(466):. PubMed ID: 28196907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
